Goodbody Health Limited
GDBYF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 7/31/2018 | |
|---|---|---|---|---|
| Market Cap | $223 | $114 | $196 | $4,610 |
| - Cash | $6,068 | $1,873 | $1,993 | $57 |
| + Debt | $337 | $500 | $621 | $0 |
| Enterprise Value | -$5,508 | -$1,259 | -$1,176 | $4,553 |
| Revenue | $17,058 | $1,994 | $1,449 | $452 |
| % Growth | 755.5% | 37.6% | 220.3% | – |
| Gross Profit | $8,931 | $1,124 | $754 | $0 |
| % Margin | 52.4% | 56.4% | 52% | 0% |
| EBITDA | -$14 | -$4,120 | -$3,293 | -$175 |
| % Margin | -0.1% | -206.6% | -227.3% | -38.7% |
| Net Income | -$2,314 | -$4,659 | -$3,798 | -$349 |
| % Margin | -13.6% | -233.7% | -262.1% | -77.1% |
| EPS Diluted | -0.067 | -0.29 | -0.48 | -0.17 |
| % Growth | 76.9% | 39.6% | -182.4% | – |
| Operating Cash Flow | $1,856 | -$2,348 | -$2,613 | -$76 |
| Capital Expenditures | -$254 | -$246 | -$525 | -$8 |
| Free Cash Flow | $1,602 | -$2,594 | -$3,138 | -$85 |